Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

12 Simple Decor Choices That Instantly Make Your Home Look More Expensive Near-Earth asteroid Bennu could hit Earth in 157 ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

The is open to all ages of people who live with chronic pain for whatever reason and are seeking consistent ways to manage that pain. For more information, call 816-275-7075. Advertisement ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

Between 40% to 70% of veterans suffer from chronic pain, and back pain is most commonly reported ... The new study appears in ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...